A new study published in Nature Communications suggests that a simple nasal swab could one day become a powerful tool for detecting Alzheimer’s disease in its earliest stages—potentially years before memory loss or cognitive symptoms begin. Researchers found that cells collected from deep inside the nasal cavity, where smell-related nerve cells reside, may carry early biological signals of the disease. By analyzing gene activity in these cells, scientists were able to identify patterns linked to Alzheimer’s, offering a promising new window into brain health without needing invasive procedures.
The approach builds on long-standing evidence that the sense of smell is closely tied to Alzheimer’s progression. Loss of smell is often one of the earliest warning signs, reflecting changes in brain regions affected early in the disease. Because the olfactory system is directly connected to the brain, researchers believe nasal tissue can act as a proxy for neurological activity. In the study, scientists identified dozens of genes that behaved differently in people with Alzheimer’s compared to healthy individuals, including those who had biological markers of the disease but no symptoms yet.
Importantly, the nasal swab test is quick, minimally invasive, and could be performed in an outpatient setting. In this early research involving a small group of participants, the method correctly distinguished individuals with early or diagnosed Alzheimer’s from healthy controls about 81% of the time. Unlike current diagnostic tools—such as brain scans, blood tests, or spinal taps—which often detect the disease after significant damage has occurred, this technique may allow clinicians to identify changes much earlier and intervene sooner.
While the findings are encouraging, researchers emphasize that the work is still in its early stages. Larger studies are needed to confirm accuracy and determine how well the test works across diverse populations. If validated, however, this nasal swab approach could represent a major shift in Alzheimer’s detection—making early diagnosis more accessible and opening the door to treatments that could slow or even prevent disease progression before symptoms appear.
To read more about the study in Nature Communications from a story in TIME magazine, CLICK HERE.
